Entity > Corporation > US > New York City New York > Neurocrine Biosciences
About Neurocrine Biosciences
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Neurocrine Biosciences
| Company Attribute | Value |
| Name | Neurocrine Biosciences |
| Url | neurocrine |
| Wikidata | wikidata |
Neurocrine Biosciences
New York City, US
18 Apr 2024
Neurocrine Biosciences
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.neurocrine.com/
Neurocrine Biosciences is dedicated to providing breakthrough treatments for patients in need with rare and under-addressed diseases.
People Also Ask
https://www.neurocrine.com › pipeline
Our Pipeline. We have a robust pipeline of investigational therapies with the potential to address unmet clinical needs of patients.
https://www.neurocrine.com › work-with-us
Browse job opportunities with Neurocrine Biosciences and come help us bring life-changing medicines to patients.
https://www.neurocrine.com › about-us
Neurocrine Biosciences is focused on unlocking new discoveries for rare and under-addressed neurological, neuroendocrine, and neuropsychiatric conditions.
https://www.neurocrine.com › contact
Neurocrine Biosciences Corporate Headquarters. 12780 El Camino Real San Diego, CA 92130. Telephone: (858) 617‑7600. Medical Information.
https://en.wikipedia.org › wiki › Neurocrine_Biosciences
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO ...
https://www.linkedin.com/company/neurocrine
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, ...
https://neurocrine.gcs-web.com › press-releases
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, ...
https://www.neurocrine.com › diseases-and-conditions
Neurocrine Biosciences is invested in finding treatments for neurological, neuroendocrine, and neuropsychiatric disorders.
https://www.neurocrine.com › approved-medicines
Neurocrine Biosciences has a developed FDA-approved treatments addressing tardive dyskinesia, Parkinson's disease, and women's health.
Related Searches
neurocrine biosciences address
neurocrine biosciences number of employees
neurocrine biosciences gene therapy
Related Searches
Knowledge Panel
Neurocrine Biosciences (Biotechnology company)
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.
-
Stock price : NBIX (NASDAQ) $134.06 +0.83 (+0.62%)Apr 18, 10:33 AM EDT - Disclaimer
-
CEO : Kevin C. Gorman (Jan 2008–)
-
Founder : Kevin C. Gorman
-
Headquarters : San Diego, CA
-
President : Kevin C. Gorman
-
Founded : 1992, San Diego, CA
| Entity Home | Kalicube Pro Entity Page |